• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these medications can affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should evaluate the benefits of using it against the possible risks to the foetus. Physicians don't have the data needed to make unequivocal recommendations but they can provide information regarding risks and benefits that aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at a greater risk of fetal malformations or structural birth defects. Researchers used a large population-based study of case control to assess the frequency of structural defects that were major in infants who were born to mothers who used stimulants during pregnancy. Pediatric cardiologists and clinical geneticists examined the cases to ensure an accurate case classification and to limit the possibility of bias.

However, the researchers' study was not without its flaws. The researchers were unable, in the first place to distinguish the effects triggered by the medication from the disorder. This limitation makes it difficult to know whether the limited associations observed in the groups that were exposed result from medication use or confounding by comorbidities. Researchers also did not examine long-term outcomes for the offspring.

The study did find that infants whose mothers took ADHD medications during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or cut back on their medications prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not affected by the stimulant medications used during pregnancy.

Women who used stimulant inattentive adhd medication adults medication during pregnancy were also at an elevated risk of having a caesarean delivery or having a baby born with an low Apgar score (less than 7). These increases did appear to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medications during early pregnancies can be offset by greater benefits to both baby and mother of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, when possible, assist them in developing strategies to improve their coping abilities which can reduce the impact of her disorder on her daily life and relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are usually made without clear and reliable evidence. Instead, doctors must consider their own expertise, the experience of other doctors and the research on the subject.

The issue of potential risks for infants can be difficult to determine. The research that has been conducted on this topic is based on observations instead of controlled studies and a lot of the results are in conflict. Additionally, the majority of studies limit their analysis to live births, which could underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these issues by looking at data from both live and deceased births.

Conclusion A few studies have found an association between ADHD medications and certain birth defects however, other studies haven't established a link. The majority of studies show that there is a neutral, or somewhat negative, impact. In each case it is imperative to conduct a thorough analysis of the benefits and risks should be conducted.

For women suffering from adhd medication names, the decision to stop medication can be difficult, if not impossible. In a recent article in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. A loss of medication may also impact the ability to safely drive and complete work-related tasks, which are vital aspects of daily life for those with adhd medication uk buy.

She suggests that women who are not sure whether to take the medication or stop it due to their pregnancy educate family members, coworkers, and acquaintances about the condition, the impact on daily functioning and the benefits of continuing the current treatment. It will also help a woman feel confident about her decision. Certain medications can pass through the placenta. If the patient decides to not take her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her infant.

Birth Defects and Risk of

As the use and use of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (cheapest adhd medication), increases as does the concern about the potential effects of these drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Researchers used two huge datasets to analyze more than 4.3 million pregnant women and determine whether stimulant medications increased birth defects. While the overall risk is low, the researchers did find that first-trimester exposure to ADHD medications was associated with an increase in the risk of certain heart defects like ventriculo-septal defects (VSD).

The researchers of the study found no link between early use of medication and other congenital anomalies, like facial clefting, or club foot. The results are consistent with previous studies revealing a small but significant increase in the risk of heart malformations among women who started taking ADHD medications prior to the time of pregnancy. This risk increased in the later part of pregnancy, when a lot of women decide to stop taking their ADHD medications.

Women who used ADHD medications in the first trimester of their pregnancies were also more likely to undergo a caesarean section, a low Apgar score following delivery, and a baby that required breathing assistance at birth. However the researchers of the study were unable to eliminate selection bias by restricting the study to women who did not have any other medical issues that could have contributed to the findings.

Researchers hope that their study will help doctors when they see pregnant women. They suggest that although discussing the benefits and risks is important however, the decision to stop or continue medication should be based on the woman's needs and the severity of her ADHD symptoms.

The authors also advise that even though stopping the medication is an option, it is not an option that is recommended due to the high rate of depression and other mental health problems for women who are expecting or who are recently postpartum. Furthermore, research suggests that women who choose to stop taking their medication are more likely to experience a difficult time getting used to life without them after the baby's arrival.

Nursing

It can be overwhelming to become a mom. Women who suffer from ADHD who have to manage their symptoms while attending doctor appointments, preparing for the arrival of a baby and adjusting to new household routines may face a lot of challenges. This is why many women decide to continue taking their most popular adhd medication medications throughout the course of pregnancy.

The majority of stimulant medications are absorbed through breast milk in small amounts, therefore the risk for nursing infant is very low. However, the amount of exposure to medication by the newborn can vary depending on the dosage, frequency it is administered, and the time of the day the medication is administered. In addition, different medications enter the baby’s system through the gastrointestinal tract, or through breast milk. The impact on a newborn's health is not completely understood.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the lack of research. This is a complicated decision for the patient, who must balance the benefits of continuing her medication with the potential risks to the foetus. Until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal period.

A growing number of studies have proven that the majority of women are able to safely continue taking their ADHD medication while they are pregnant and nursing. As a result, an increasing number of patients choose to do so and, after consulting with their doctor, they have found that the benefits of continuing their current medication outweigh any risks.

It is essential for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD recognize their symptoms and the root cause, learn about available treatments and to reinforce existing strategies for coping. This should involve a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. Pregnancy counselling should include discussion of a management plan for both mother and child, as well as monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.